Clinical Trials Directory

Trials / Unknown

UnknownNCT04579406

Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients

Association of Changes in NPY, CGRP, SP and TRPV1 With Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Second Hospital of Shanxi Medical University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The study was designed to investigate the correlation between perioperative adverse cardiovascular events and the degeneration of sensory nerves in patient diagnosed with type 2 diabetes mellitus, undergoing elective non-cardiac surgery.

Detailed description

The study was designed to investigate the correlation between perioperative adverse cardiovascular events and the degeneration of sensory nerves in patient diagnosed with type 2 diabetes mellitus, undergoing elective non-cardiac surgery. Diabetes mellitus and peripheral sensory nerve degeneration will be diagnosed via clinical evaluation. Serum levels of constituent neuropeptides, including neuropeptide Y (NPY), calcitonin and substance P (SP) and calcitonin gene related peptide (CGRP), and transient receptor potential vanilloid 1 (TRPV1), a molecular nociceptor in peripheral sensory nerves will be quantitatively evaluated. The clinical and the biochemical consequence will be compared between the cohorts of diabetic and non-diabetic patients. The differences and the correlations will be analyzed. The results of the study may reveal whether or not the perioperative adverse cardiovascular events in diabetic patients are correlated with degeneration of peripheral sensory nerves and the alterations in the neuropeptides and TRPV1 are potentially applicable for evaluation of the risk of cardiovascular events in perioperative period in diabetic patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREnon-cardiac surgeryAll the patients are undergoing non-cardiac surgery.

Timeline

Start date
2020-10-15
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2020-10-08
Last updated
2023-04-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04579406. Inclusion in this directory is not an endorsement.